US-based biopharmaceutical services provider Parexel International has opened Clinical Logistics Services facilities in Singapore and Russia to address growing industry demand for handling and transport of clinical trial supplies in emerging markets.
The new depot in Singapore and ancillary warehouse in Russia expand on an existing infrastructure established by Parexel’s Clinical Logistics Services Group across North America, Latin America, Europe and the Asia Pacific region.
The Singapore depot will handle the distribution of investigational medicinal products and non-investigational medicinal products as well as ancillary supplies for clinical trials conducted by Parexel, the company said.
The ancillary warehouse in Russia is for storage of any non-drug materials required for clinical trials in Russia, including laboratory kits, drug application materials and medical supplies and equipment, as well as documents such as patient diaries and questionnaires.
The new facilities feature 24/7/365 monitoring systems and incorporate client services such as inventory management and return/destruction capabilities.
“The opening of these new facilities within our global Clinical Logistics Services infrastructure positions us to meet increasing client demand for high-quality clinical trial supplies handling and transport in emerging regions,” commented Dr Joe Avellone, corporate vice president, clinical research services for Parexel.
Singapore is a leading logistics hub for the Asia/Pacific region, with best-in-class transportation performance and favorable import/export regulations, Avellone noted.
The dedicated warehousing capabilities in Russia will help clients to reduce the time and costs involved in transporting supplies to trial sites in the country, as study materials have to be imported into Russia well in advance of investigational site distribution, he added.